Mesothelioma Genetic Research Team Receives $2.6M Grant from NIH

Dr. Michele Carbone at the University of Hawaii Cancer Center has good reason to start 2020 optimistic about advancing the treatment of malignant pleural mesothelioma. The National Institutes of Health awarded his research team a five-year, $2.6 million grant last month to continue its work linking the BAP1 gene mutation to the development of mesothelioma cancer. It may hold the key to an eventual cure. “This [grant] moves us in the right direction. There is reason to be hopeful,” Carbone told The Mesothelioma Center at Asbestos.com. “There is one thing left to do, develop the resources to cure this horrible cancer. That’s the goal.” UH a Leader in Mesothelioma Research The University of Hawaii Cancer Center is the leader in U.S. federal funding for mesothelioma research, much of it stemming from the work of Carbone and co-leader Dr. Haining Yang. Their team was the first to uncover the genetic link to mesothelioma, identifying the BAP1 mutation almost a decade ago. It remains the only mutation proven to have a direct tie to the cancer. Researchers also believe that same mutation holds the key to future developments in early detection, prevention and treatment for mesothelioma. Free Mesothelioma Guide Our latest guide for patients and loved ones is shipped overnight and includes medical and legal information, mesothelioma books and support ...
Source: Asbestos and Mesothelioma News - Category: Environmental Health Authors: Source Type: news